Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 3
This trial looked at tivantinib and erlotinib for non small cell lung cancer that had got worse despite other treatment. It was for people with non squamous cell cancer, such as or .
The trial was open for people to join between 2011 and 2012. The team published the results in 2015.
Recruitment start: 1 February 2011
Recruitment end: 31 July 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Conrad Lewanski
ArQule Inc
Daiichi Sankyo
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 06 Jul 2023
CRUK internal database number: 8576
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
